FDA orders recall of 2,800 scope-washing machines

About 2,800 automated endoscope reprocessors made by Custom Ultrasonics are used by hospitals and outpatient clinics in the U.S.


Federal regulators have ordered a Pennsylvania company to recall its scope-cleaning machines used at UCLA and more than 1,000 other hospitals and clinics, according to an article on the L.A. Times website.

The Food and Drug Administration said Custom Ultrasonics had continued to violate federal law and those lapses could result in an increased risk of infection for patients.

About 2,800 automated endoscope reprocessors made by Custom Ultrasonics are used by hospitals and outpatient clinics in the U.S.

In 2012, the FDA told the company to stop manufacturing and ordered a recall of devices. But the equipment was allowed to remain on the market after the company made changes.

Read the article.

 

 



November 20, 2015


Topic Area: Safety


Recent Posts

Contaminants Under Foot: A Closer Look at Patient Room Floors

So-called dust bunnies on hospital room floors contain dust particles that turn out to be the major source of the bacteria humans breathe.


Power Outages Largely Driven by Extreme Weather Events

Almost half of power outages in the United States were caused by extreme weather events.


Nemours Children's Health Opens New Moseley Foundation Institute Hospital


Code Compliance Isn't Enough for Healthcare Resilience

Intensifying climate risks are pushing hospitals to think beyond code requirements and toward long-term resilience.


Ribbon Cutting Marks First Phase Completion for New Montefiore Einstein Facility

The second phase is expected to be completed in the second half of 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.